This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Big Stock Trades Signaling 'Buy'


One stock that hasn't benefitted from the S&P's 2013 climb is Amgen (AMGN - Get Report), the $64 billion pharmaceutical stock. Instead, Amgen has mostly churned sideways this year. But that could be about to change thanks to a bullish setup that's been forming in shares.

>>5 Dividends That Are About to Get Bigger

Amgen is currently forming an ascending triangle pattern, a technical setup that's formed by a horizontal resistance level to the upside and uptrending support sitting right below shares. Essentially, as AMGN bounces in between those two technical price levels, it's getting squeezed closer and closer to a breakout above resistance at $90. When the breakout happens, we've got a buy signal for this stock.

Pharmaceutical names have been acting "funny" for the last few months, stumbling only to make a move higher. That's good enough reason to keep a tight stop on AMGN. The 200-day moving average is becoming a pretty good proxy for support right now, so it's a reasonable place to put your stop.
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ACT $0.00 0.00%
AMGN $151.96 -1.50%
EQT $70.40 1.20%
LKQ $32.28 -0.19%
MSFT $49.89 -0.10%


Chart of I:DJI
DOW 17,657.19 -3.52 -0.02%
S&P 500 2,045.40 -5.23 -0.26%
NASDAQ 4,696.5620 -20.5320 -0.44%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs